Palo Alto Health Sciences names Christopher S. Lento, MBA as Chief Commercial Officer

Wednesday, November 28, 2018 General News
Email Print This Page Comment bookmark
Font : A-A+

Christopher S. Lento brings extensive healthcare leadership & commercialization experience to Palo Alto Health Sciences, Inc.

KIRKLAND, Wash., Nov. 28, 2018 /PRNewswire/ -- Palo Alto Health Sciences, Inc. (PAHS), the manufacturer of Freespira®,

the only FDA-cleared digital therapeutic for treating panic attacks and panic related disorders, is pleased to announce the addition of Christopher S. Lento, MBA to its Senior Executive team. Chris will serve as Chief Commercial Officer and a key member of PAHS' leadership team, leading efforts as PAHS continues to expand its US footprint and commercial operations. Chris has over 26 years of experience in the pharmaceutical, biotechnology, medical device, and healthcare technology sectors. He joins PAHS from Pear Therapeutics, a leading digital health organization that treats patients diagnosed with substance abuse and opioid use disorders using innovative prescription digital therapeutics. Chris was the company's first commercial employee and served as Vice President of Commercial Operations, developing a successful go-to-market strategy.

"I am honored to join Palo Alto Health Sciences at a critical time in their corporate development.  As more and more people gain access to Freespira, results consistently show the treatment is a cost-effective long term solution for reducing the symptoms of panic attacks. There is an enormous opportunity to positively impact the quality of life for people suffering from this debilitating condition," said Chris.  "We are thrilled to have Chris join the team, and are confident his professional experience, diverse healthcare background, and passion for the mental health field will help us scale quickly," said Debra Reisenthel, Founding CEO of Palo Alto Health Sciences, Inc.

About Palo Alto Health Sciences, Inc. and Freespira®

Palo Alto Health Sciences, Inc. is a privately held digital therapeutic company offering Freespira, an innovative treatment option for people suffering from panic disorder and panic attacks. Freespira is the only FDA-cleared, evidence-based, drug-free solution that is proven to reduce symptoms of panic and panic related disorders after only one month.

www.Freespira.com – (800) 735-8995

 

Cision View original content:http://www.prnewswire.com/news-releases/palo-alto-health-sciences-names-christopher-s-lento-mba-as-chief-commercial-officer-300756673.html

SOURCE Palo Alto Health Sciences



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store